Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer
Conditions
- Neoplasms
- Triple Negative Breast Cancer
- Ovarian Cancer
- Breast Cancer
- Metastatic Breast Cancer
- Advanced Breast Cancer
- Stage IV Breast Cancer
- Fallopian Tube Cancer
- Peritoneal Cancer
Interventions
- DRUG: niraparib
- BIOLOGICAL: pembrolizumab
Sponsor
Tesaro, Inc.
Collaborators